Etodolac (foreign-made) in the Philippines
Quick answer
This entry is etodolac made abroad, as sold online. No etodolac product of any brand is registered with FDA Philippines (checked 2026-11-05), so it may not be sold here (RA 9711). The DOH price index has no entry for etodolac.
Strengths
Etodolac strengths
Etodolac is listed in 3 strengths; none of them matches an FDA-registered product in the Philippines.
| Strength | Generic page | Registered here |
|---|---|---|
| 200 mg | Etodolac 200 mg | no |
| 300 mg | Etodolac 300 mg | no |
| 400 mg | Etodolac 400 mg | no |
Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.
Paying less for etodolac
- Ask for the generic
Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works
- Senior or PWD card
20% off plus no VAT on your own medicines, with ID and prescription. What to bring
Questions people ask
Is Etodolac registered with FDA in the Philippines?
No product named Etodolac appears in the FDA Philippines registry (checked 2026-11-05). No etodolac product is registered either, so it may not be sold here (RA 9711).
How much is Etodolac in the Philippines?
The DOH Drug Price Reference Index (June 2024 edition) has no entry for etodolac, so there is no official reference price. Ask two or three licensed drugstores for the price of the same strength, branded and generic.
Can I buy etodolac in the Philippines?
No etodolac product is registered with FDA Philippines (checked 2026-11-05), so no drugstore may legally sell it here (RA 9711), and products offered online are not supervised by FDA. Ask your doctor about a registered alternative.
No product named Etodolac appears in the FDA Philippines registry; neither does any product with this ingredient. A medicine that is not registered with FDA Philippines may not be sold here (RA 9711). If you are offered it, check the registration number first.
Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.